Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Hologic
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:CEO |
Nicolas Barthelemy
|
| gptkbp:focusesOn |
cancer diagnostics
|
| gptkbp:foundedYear |
2008
|
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:offersProduct |
gptkb:Breast_Cancer_Index
CancerTYPE ID |
| gptkbp:parentCompany |
gptkb:Hologic
|
| gptkbp:servesArea |
gptkb:United_States
|
| gptkbp:specializesIn |
molecular diagnostics
|
| gptkbp:website |
https://biotheranostics.com/
|
| gptkbp:bfsParent |
gptkb:Breast_Cancer_Index
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
BioTheranostics
|